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Conclusions: The QA process resulted in protocol compliant plans, 
generally improving based on the investigated criteria. The lack of 
differences in target coverage between sIMRT and rIMRT plans may 
partly be a result of the QA process ensuring comparability across the 
trial, however the more homogeneous dose distributions resulting 
from the rIMRT requires further investigation. 
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Purpose/Objective: To develop an analysis method for pretreatment 
verification based on the MLC leaf opening times (LOTs) measured 
with the imaging detector of the tomotherapy system. 
Materials and Methods: Twenty-five treatments from two 
tomotherapy units were delivered and acquired by the imaging 
detector of the system. Based on the fluence measured in the 
detector, LOTs of each treatment were extracted. 
LOTs at each gantry angle were summed taking into account the 
position of the beam at each projection calculated from treatment 
parameters such us field width and pitch, leading to a composite 
fluence map at each of the 51 gantry angles in which the tomotherapy 
system divides a rotation. These fluence maps have time units, and 
allow for analysis methods similar to those of field-by-field 
pretreatment verification. 
Mean differences in time between planned and delivered fluences, as 
well as standard deviation of that error distributions were obtained. 
Percentages of points within a 1%, 2%, 3% and 5% of the mean time of 
each treatment were also used in the analysis. 
These parameters were compared with conventional pretreatment 
verification methods on a cylindrical virtual water phantom. 
Results: Mean results of both machines are shown in the table, results 
show a good performance of both tomotherapy systems. Mean time 
errors lie within a 1% in all of the cases with standard deviations 
within a 3%. Those small differences in mean time errors suggest that 
important differences in dose are not caused by the MLC.  
Employing a 90 % of passing points as a threshold value for the 5% test 
would imply that only two of the treatments would have been 
rejected, while almost half of the treatments would have been 
rejected with the 3% criterion. Nevertheless, all of the treatments 
passed the verification based on ionization chamber and film. 
Therefore, the percentage of points within a 5% appears to be a good 
criterion for pretreatment verification, as it yields results similar to 
those obtained with our actual method based on the gamma index. 
No correlation was found between the results of the gamma index 
with those of fluence per angle. Gamma index results depend more on 
parameters such us treatment volume or shape of the dose 
distribution, while fluence results are more related with projection 
time and mean LOTs. 
 
 Mean values 
Tomotherapy 
1 
Tomotherapy 
2 
Cylindrical phantom 
verification 
Dose difference 
(%) -0,9 0,1 
% passing Gamma 
(3% 3mm) 99,3 98,1 
Imaging detector 
verification 
Time error (%) 0,4 0,2 
St. dev. of time 2,1 1,8 
error (%) 
% of points within 
1% 45,6 54,1 
% of points within 
2% 71,2 79,6 
% of points within 
3% 84,8 90,6 
% of points within 
5% 95,7 97,7 
 
Conclusions: A method for pretreatment verification based on fluence 
measurements with the on-board imaging detector was analyzed. The 
percentage of points within a 5% of the mean fluence time seems to 
be the more appropriate index for pretreatment verification. 
Nevertheless, treatments that passed the verification with 
conventional methods failed the proposed index. Therefore,further 
analysis on this matter should be developed.  
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Purpose/Objective: Complement existing EPID-based QA procedures 
for linear accelerators with specific VMAT tests covering the 
additional involved elements: dynamic MLC, dose modulation, gantry 
speed modulation and dose delivery during gantry rotation. 
Materials and Methods: Four different MLC types were used in this 
study: Varian Millennium™120MLC & HD120™MLC, and Elekta MLCi2 & 
Beam Modulator™. Tests criterions described in the commissioning 
procedure proposed by Ling et al. [Ling2008] were adapted 
- Test 1: leaf positions test using picket fence (PF) patter acquired at 
different gantry angles and during gantry rotation. 
- Test 2: variation of dose rate and gantry speed during gantry 
rotation. 
- Test 3: variation of dose rate and MLC leaf speed during gantry 
rotation. 
Some adaptations were done in order to take into account the 
differences in capabilities and geometry between the MLCs and 
accelerators, as well as to use EPID instead of films. On Varian Linacs, 
the EPID acquisition was done using fields of the DICOM RT Plans 
provided by the manufacturer. On Elekta Linacs it was done using the 
iComCAT software. The analysis of acquired EPID images was 
performed automatically using ARTISCAN (software solution developed 
by AQUILAB SAS, France). 
Results: All the key elements were correctly automatically detected 
in EPID images of all devices, regardless of the problems impacting 
image quality (Noise, Flexmap…). 
Test 1 was analyzed on 3 criterions for each slit of the PF: position of 
slit center, FWHM of the slit and dose delivered in the slit. In all the 
cases, every slit was correctly detected. The evaluation of the slit 
center position was sensitive enough to detect offset as small as 
0.5mm. The delivered dose was also a good indicator of leaf position 
errors. However, FWHM is not a good indicator as it did not correlate 
with induced width changes of the PF. 
Test 2 showed good homogeneity of the delivered dose regardless of 
the gantry speed or the dose rate on all devices. However, for close-
to-maximum gantry speed, slight dose rate fluctuations can occur. 
Test 3 showed a good homogeneity of the dose delivered on Varian 
devices. On the Elekta Beam Modulator, images showed lower 
delivered dose on the left and right borders of the test pattern. 
Repeated occurrences of test 2 and 3 over multiple days showed 
consistency of the results over time. 
Conclusions: Criterions tested in the Ling et al. commissioning 
procedure are as relevant for VMAT-capable Elekta linacs as they are 
for RapidArc-capable Varian linacs. The use of an automated solution 
to analyze EPID images ensures an objective, quantitative, as well as 
fast analysis for QA. However these criterions do not cover all the 
potential sources of error and additional tests will be evaluated. 
[Ling2008] Ling et al. 'Commissioning and quality assurance of 
RapidArc radiotherapy delivery system.' IJROBP 72.2 (2008): 575-581. 
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Purpose/Objective: The sensitivity of QA protocols is tested for the 
novel Elekta AgilityTM MLC (5 mm leaf width) and the widely used 
Elekta MLCi2 (10 mm leaf width) using both a 2D ionization chamber 
array (MatriXXevolution, iba dosimetry) and a 2D diode array 
(MapCHECK 2, Sun Nuclear). 
Materials and Methods: Geometric characterisation includes 
detection of leaf and jaw penumbra as well as detection of leaf 
misalignments using a 'comb field' with shifts of adjacent leaves 
ranging from 1 to 5 mm. Further accuracy checks are done evaluating 
tongue-and-grove,stair pattern and picket fence test. These fields are 
measured in original setup position and with the devices shifted half a 
leaf towards the gantry. Results are compared against EBT3 film and 
Monte Carlo dose calculations. Dosimetric accuracy is checked against 
a Farmer-type ionisation chamber (FC) with respect to dose linearity 
and dose summation. 
Results: Dose linearity and dose summation for MatriXX is always 
consistent (<0.5 %) with the FC. MapCHECK shows consistency (<0.5 %) 
for doses higher than 15 cGy. Smaller doses (2 cGy) are measured with 
up to -3 % deviation. Penumbras measured with MapCHECK are 
consistent with film measurements. Depending on the steepness of 
the penumbra, MatriXX shows up to 2.8 mm wider penumbras. 
Measurements of the comb field show that both devices detect leaf 
misalignments down to 1mm. However, the amount of the dose 
perturbation is highly dependent on the geometry of the misaligned 
leaf relative to the detector geometry, especially for the smaller leaf 
widths of the Agility MLC (5 mm). Accuracy checks show higher 
sensitivity of leaf misalignments for MapCHECK. Combining original 
and shifted measurements, MatriXX provides the same information. 
Conclusions: Both arrays are suitable for 2D dose measurements, even 
though every device has specific strengths. MatriXX performes better 
for dose linearity and dose summation due to the use of ionization 
chambers. MapCHECK is advantageous in MLC accuracy measurements 
due to the detector geometry setup and the point-like detection 
characteristics of diode detectors. Using either array with MLCi2 (10 
mm), each device will provide sufficient measurements for patient 
specific QA using a Gamma Index 3% / 3mm. However, the smaller the 
leaves the better MapCHECK will detect leaf misalignments. MatriXX 
performs better if many subfields have small MU. Using the devices for 
machine QA, it is highly important to design tests in accordance to the 
measurement geometry. Especially for MatriXX measurements with 
small MLCs (e.g. Agility) measurements of original and shifted setups 
need to be combined for sufficient MLC QA. 
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Purpose/Objective: The traditional way to take time into account in 
Monte Carlo (MC) simulations is to simulate individual static 
component fields separately and integrate the results. This method 
can be very efficient but leads to a high demand of phase space file 
storage. To avoid this, the position probability sampling (PPS) method, 
in which the position of a geometrical object is treated as a random 
variable during the simulation, has been developed. We aim here to 
incorporate this method in Penelope in the case of a virtual wedge. 
Materials and Methods 
II.1 Monte Carlo simulation: We have used the 2006 release of the 
Penelope code with a new version of the main program Penmain, in 
which several conventional variance reduction techniques were 
implemented in order to increase the efficiency of the linac 
treatment head simulations. The MC code was used to model both the 
Siemens Artiste linac with a full description of the Siemens 160 MLC 
and the OptiVueTM 1000 EPID (Siemens Medical Solutions).  
To model the dynamic jaw motion of the virtual wedge, the PPS 
method has been implemented in Penmain. This implementation 
required an adequate modelling of the jaws to allow their motion 
without a complete re-initialization of the geometry for each particle. 
We have thus written a new subroutine which needs as inputs: the 
index of the moving jaw surface, the first and last positions of the 
moving jaw, the wedge angle α, and the value of (C x μ) with μ the 
effective linear attenuation coefficient in water for the particular 
photon spectrum, and C a tuning coefficient for μ.  
II.2 Measurements  
All the measurements have been performed on a Siemens Artiste linac 
with a 20 cm x 20 cm field size and for a 6 MV photon beam. A first 
set of measurements has been performed in a water tank positioned 
at 100 cm skin source distance. Wedged beam profiles have been 
measured with a linear detector array at three different depths: 1.5 
cm, 5 cm, and 10 cm. Then a portal image of a 40° wedged beam has 
been acquired at 145 cm detector source distance without any 
phantom in the beam.  
Results: We have first performed MC simulations for the 45° wedged 
beam in a water tank and we have reported the dose distribution in a 
4 x 3 x 2.5 mm3 scoring grid. The profiles have been extracted and 
compared with the experimental ones. We have then simulated the 
acquisition of the portal image of a 45° wedged beam with the EPID's 
physical resolution (0.39 mm). The results are reported in figure 1. 
 
  
Conclusions: In this work the PPS method was used to incorporate the 
collimator motion into Penelope. A 6 MV photon beam of a Siemens 
Artiste linac equipped with a 160 MLC and an OptiVueTM 1000 EPID 
(Siemens Medical Solutions) was simulated with a virtual wedge. 
Measurements and simulations have been performed in a water tank 
and in the portal device. The simulated dose profiles reproduce the 
experimental data with a fairly good accuracy.  
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Purpose/Objective: With the potential improvement of dose 
conformality of protons over photons, the number of new proton 
treatment centres is increasing rapidly. One of the key physics 
decisions for a new centre is the choice of treatment planning system 
and one of the first important tasks facing the physics team is beam 
commissioning. Proton beam commissioning consists of modelling 
pristine Bragg peaks and lateral profiles for the range of energies to 
be used clinically. Both are equally important as they effectively 
define the proximal/distal and lateral beam penumbrae respectively. 
This study analyses the performance of beam configuration modules of 
two treatment planning systems: commercially-available Eclipse 
(v10.0.39) and research-only Pinnacle (v9.1, Feb 2012).  
Materials and Methods: Pristine Bragg peaks (for 27 energies between 
100-226.7MeV) from the University of Pennsylvania horizontal fixed 
beam line were acquired in a water tank with a 42mm measurement 
offset (water tank wall, surface offset and chamber offset). Lateral 
profiles were acquired at 8 positions in air, for each energy, using 
IBA’s Lynx scintillator/CCD camera system. The depth dose curves and 
profiles were modelled by both systems using their respective 
automated fitting tools. After resampling the measured and fitted 
datasets to a consistent high resolution, the fitting quality was 
assessed using gamma analysis with a 2%/2mm criteria for depth dose 
curves and a 2%/0.1mm criteria for lateral profiles. The tighter 
distance-to-agreement criterion was required for profiles to ensure 
the analysis did not reach a false local minimum. 
Results: Both models were within clinical tolerances, however their 
algorithms differ and so there were slight differences in the fitting. 
For energies E>180MeV in Eclipse the entrance dose in the depth dose 
curves was underestimated (by up to 2.5%), while Pinnacle 
consistently overestimates the distal Bragg peak depth with a mean 
distal R50 error of 0.3mm. The mean gamma index for the profiles, 
